Medtronic plc Cash Flow-to-Debt Ratio
Medtronic plc cash flow-to-debt ratio. Medtronic plc (MDTC34) has a Cash Flow-to-Debt Ratio of 0.06x as of April 2026, meaning its operating cash flow of R$2.57 Billion could theoretically repay 0% of its total liabilities (R$42.96 Billion) in one year. Check how high is Medtronic plc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medtronic plc (2019–2026)
Cash flow-to-debt ratio of Medtronic plc from 2019 to 2026. Historical debt coverage capacity for Medtronic plc across 8 annual periods. Check Medtronic plc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Medtronic plc Cash Flow-to-Debt Ratio by Year (2019–2026)
Medtronic plc cash flow-to-debt ratio by year from 2019 to 2026. Year-by-year debt coverage analysis for Medtronic plc. For the full cash flow conversion analysis, see how efficiently does Medtronic plc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (BRL) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.17x | R$7.33 Billion | R$42.96 Billion | ▲ +5.2% |
| 2025 | 0.16x | R$7.04 Billion | R$43.42 Billion | ▼ -5.0% |
| 2024 | 0.17x | R$6.79 Billion | R$39.77 Billion | ▲ +11.5% |
| 2023 | 0.15x | R$6.04 Billion | R$39.47 Billion | ▼ -20.3% |
| 2022 | 0.19x | R$7.35 Billion | R$38.26 Billion | ▲ +27.6% |
| 2021 | 0.15x | R$6.24 Billion | R$41.48 Billion | ▼ -17.2% |
| 2020 | 0.18x | R$7.23 Billion | R$39.82 Billion | ▲ +2.4% |
| 2019 | 0.18x | R$7.01 Billion | R$39.48 Billion | — |